Tetrahydro-5,6-dimethyl-2H-pyran-2-one
Common Name: |
Tetrahydro-5,6-dimethyl-2H-pyran-2-one |
IUPAC Name: |
5,6-dimethyloxan-2-one |
Molecular Formula: |
C7H12O2 |
SMILES: |
CC1CCC(=O)OC1C |
Inchi: |
1S/C7H12O2/c1-5-3-4-7(8)9-6(5)2/h5-6H,3-4H2,1-2H3 |
Inchi Key: |
HAXARIVGMMVELD-UHFFFAOYSA-N |
Cas No: |
10413-18-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
128.17 |
Mass (g/mol) |
128.084 |
Molar Refractivity |
34.93 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
0 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
9 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
214.00 to 216.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.12 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.86 |
LogP |
1.348 |
iLOGP |
1.79 |
XLOGP3 |
1.41 |
WLOGP |
1.35 |
MLOGP |
1.23 |
ESOL Log S |
-1.52 |
ESOL Solubility (mg/ml) |
3.84 |
ESOL Solubility (mol/l) |
0.03 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.57 |
Ali Solubility (mg/ml) |
3.48 |
Ali Solubility (mol/l) |
0.03 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.17 |
Silicos-IT Solubility (mg/ml) |
8.65 |
Silicos-IT Solubility (mol/l) |
0.07 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.08 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.335 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.38 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |